Joseph C. Galante, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 2,125 shares at $2.11 ($5K) on 2022-07-01, disclosed to the SEC on 2022-08-19.
Scheduled purchase ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.11 | 70 | $148 | 3.0% |
| 2 | $2.18 | 86 | $187 | 3.8% |
| 3 | $2.11 | 86 | $181 | 3.7% |
| 4 | $2.18 | 86 | $187 | 3.8% |
| 5 | $2.19 | 86 | $188 | 3.8% |
| 6 | $2.25 | 86 |
| $194 |
| 3.9% |
| 7 | $2.28 | 86 | $196 | 4.0% |
| 8 | $2.23 | 86 | $192 | 3.9% |
| 9 | $2.41 | 74 | $178 | 3.6% |
| 10 | $2.47 | 74 | $183 | 3.7% |
| 11 | $2.52 | 74 | $186 | 3.8% |
| 12 | $2.54 | 74 | $188 | 3.8% |
| 13 | $2.53 | 74 | $187 | 3.8% |
| 14 | $2.48 | 74 | $184 | 3.7% |
| 15 | $2.47 | 74 | $183 | 3.7% |
| 16 | $2.36 | 60 | $142 | 2.9% |
| 17 | $2.28 | 74 | $169 | 3.4% |
| 18 | $2.28 | 74 | $169 | 3.4% |
| 19 | $2.34 | 74 | $173 | 3.5% |
| 20 | $2.45 | 30 | $74 | 1.5% |
| 21 | $2.17 | 74 | $161 | 3.3% |
| 22 | $2.12 | 74 | $157 | 3.2% |
| 23 | $2.19 | 82 | $180 | 3.7% |
| 24 | $2.19 | 82 | $180 | 3.7% |
| 25 | $2.19 | 82 | $180 | 3.7% |
| 26 | $2.46 | 82 | $202 | 4.1% |
| 27 | $2.52 | 82 | $207 | 4.2% |
| 28 | $2.45 | 65 | $159 | 3.2% |
| Total | $2.31 avg | 2,125 | $5K | 100% |
| Filing → |
| CPIX | BUY | 2022-12-23 | $3K | — | Filing → |
| CPIX | BUY | 2022-11-18 | $4K | — | Filing → |
| CPIX | BUY | 2022-09-30 | $5K | — | Filing → |